Literature DB >> 22581591

Optimization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach.

Zhibiao Fu1, Julie Leighton, Aili Cheng, Edward Appelbaum, Juan C Aon.   

Abstract

Various approaches have been applied to optimize biological product fermentation processes and define design space. In this article, we present a stepwise approach to optimize a Saccharomyces cerevisiae fermentation process through risk assessment analysis, statistical design of experiments (DoE), and multivariate Bayesian predictive approach. The critical process parameters (CPPs) were first identified through a risk assessment. The response surface for each attribute was modeled using the results from the DoE study with consideration given to interactions between CPPs. A multivariate Bayesian predictive approach was then used to identify the region of process operating conditions where all attributes met their specifications simultaneously. The model prediction was verified by twelve consistency runs where all batches achieved broth titer more than 1.53 g/L of broth and quality attributes within the expected ranges. The calculated probability was used to define the reliable operating region. To our knowledge, this is the first case study to implement the multivariate Bayesian predictive approach to the process optimization for the industrial application and its corresponding verification at two different production scales. This approach can be extended to other fermentation process optimizations and reliable operating region quantitation.
Copyright © 2012 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581591     DOI: 10.1002/btpr.1557

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  2 in total

1.  Exometabolome analysis reveals hypoxia at the up-scaling of a Saccharomyces cerevisiae high-cell density fed-batch biopharmaceutical process.

Authors:  Zhibiao Fu; Thomas D Verderame; Julie M Leighton; Brante P Sampey; Edward R Appelbaum; Pramatesh S Patel; Juan C Aon
Journal:  Microb Cell Fact       Date:  2014-03-05       Impact factor: 5.328

2.  Hypoxia-elicited impairment of cell wall integrity, glycosylation precursor synthesis, and growth in scaled-up high-cell density fed-batch cultures of Saccharomyces cerevisiae.

Authors:  Juan C Aon; Jianxin Sun; Julie M Leighton; Edward R Appelbaum
Journal:  Microb Cell Fact       Date:  2016-08-15       Impact factor: 5.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.